How long can Indian stock markets defy the global correction?

The Indian stock markets have shown remarkable resilience in recent weeks even as global equities have faced intense selling pressure. The benchmark Nifty 50 index has fallen only marginally despite the US markets witnessing one of their sharpest corrections in years. The Dow Jones Industrial Average (DJIA) has plummeted by nearly 1,500 points or around […]

Bidding for Biogen’s Biosimilars – Intas Best Placed Over Samsung & Dr. Reddy’s?

A bidding war is reportedly heating up for Biogen’s biosimilars portfolio, with three major pharmaceutical companies reportedly offering around $1 billion for the business unit – Samsung Bioepis, India’s Dr. Reddy’s Laboratories, and Intas Pharmaceuticals. Of the three, Samsung and Intas may be placed to gain the maximum from the acquisition. Biogen’s biosimilars division focuses […]

Escorts Kubota Well Positioned for Growth With Kubota Partnership, Says Sharekhan

Escorts Kubota Limited (EKL), one of India’s leading tractor manufacturers, is poised for strong growth in the coming years, according to a new research report by Sharekhan. EKL, formed after the merger of Escorts Limited and Kubota Corporation of Japan, will benefit significantly from synergies and integration of the two entities, said Sharekhan in its […]

COLUMN: Is Maruti Suzuki losing the EV war?

Maruti Suzuki has enjoyed an enviable position in the Indian automobile market for decades. The company has dominated car sales in India since the 1980s, capturing over 40% market share consistently. However, recent developments have raised concerns that Maruti Suzuki may be headed down the same path as Nokia and Kodak – complacent incumbents who […]

Sobha Ltd’s hard days seem over, time for a relook- HDFC Sec

Leading brokerage HDFC Securities has come out with a positive outlook on real estate developer Sobha Ltd, stating that headwinds are largely priced in and risk-reward is now favorable for further rerating. The brokerage believes the stock’s underperformance versus real estate sector makes valuations compelling for investors to make a fresh entry. In an in-depth […]

Kotak Institutional withdraws mid-cap portfolio recommendations citing ‘irrational exuberance’

Leading Indian brokerage firm Kotak Institutional Equities has sounded the alarm on the recent rally in mid- and small-cap stocks, warning clients that the sharp increase reflects “irrational exuberance” among investors rather than fundamentals. As a result, Kotak has dropped its recommended mid-cap portfolio, saying it could not justify recommending stocks trading significantly above fair […]

As India bans computer imports, Dixon Tech smells multi-billion opportunity

Homegrown electronics manufacturing services company Dixon Technologies is betting big on domestic IT hardware production under the government’s production-linked incentive (PLI) scheme. With approvals in place, Dixon is poised to manufacture laptops, tablets, all-in-one PCs and servers in India. Dixon started operations in 1993, commencing with the assembly of colour televisions. Over the years, the […]

“Limited opportunities” to make money in Indian equity markets due to rich valuations – Kotak Sec

Opportunities for making money in the current equity markets in India are ‘limited’ given expensive valuations across sectors and potential risks of earnings-downgrades, Kotak Securities’ Private Client Group warned in its monthly update. “The future for the markets may not all be all rosy with headwinds arising also from international shores with the U.S. Fed […]

Indian equities can go higher, but money may shift to large-caps: Axis Securities

Even as worries of high valuation and rising interest rates in the US give pause to some investors, Axis Securities has reiterated its positive outlook on Indian equity markets in its latest report for September 2023. The broking arm of Axis Bank highlights that the structural trend for the market remains positive, however, it expects […]

Systematix puts a ‘buy’ on Pfizer India on drug strong pipeline

Equity research firm Systematix Institutional Equities has initiated coverage on pharmaceutical major Pfizer Ltd with a “Buy” rating and set a target price of Rs 4,954, indicating an upside potential of around 30% from current levels. The broking house said the recent slowdown in Pfizer Inc’s Indian subsidiary was due to temporary factors and its […]

Screenwriter Kriti Kapoor to make directorial debut with ‘Sorry Not Sorry’

Screenwriter Kriti Kapoor, who has served as assistant director on films like ‘Airlift’, ‘2 States’, and ‘Blood Money’, is making her directorial debut with the film ‘Sorry Not Sorry’. The upcoming comedy-drama produced by Mohaan Nadaar’s Teamo Productions revolves around a small-town girl who gets caught up in the world of social media fame and […]

Brigade Ent to build new project on Pfizer land plot in Chennai

Brigade Enterprises said it has acquired a plot of Rs 139 crores from Pfizer Healthcare India Ltd in Chennai to build a residential project. The 6.54 acre land-plot has been acquired in Sholinganallur, on the Old Mahabalipuram Road. “We will be developing a residential project on this land parcel with an overall development of over […]